NCT07701993
- Conditions
- Digestive System Diseases, Fatty Liver, Fibrosis, +4 more
- Locations
-
Not specified
Clinical trial condition
Metabolic Dysfunction-Associated Steatohepatitis
Explore clinical trials studying Metabolic Dysfunction-Associated Steatohepatitis. Study availability and eligibility vary by location and protocol.
14 public trials
7 recruiting studies
Metabolic Dysfunction-Associated Steatohepatitis trial results
Not Yet Recruiting
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)
NCT07462455
- Conditions
- Metabolic Dysfunction-Associated Steatohepatitis
- Locations
-
- Beijing Tsinghua Changgeng Hospital Beijing, China
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, China
- The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, China
- The First Affiliated Hospital of Xiamen University Xiamen, China
NCT06342947
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +5 more
- Locations
-
- Aligos Clinical Study Site 18 Chandler, Arizona, United States
- Aligos Clinical Study Site 15 Peoria, Arizona, United States
- Aligos Clinical Study Site 17 Tucson, Arizona, United States
- Aligos Clinical Study Site 35 Chula Vista, California, United States
Active, Not Recruiting
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
NCT06465186
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +6 more
- Locations
-
- The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0149) Chandler, Arizona, United States
- Arizona Clinical Trials ( Site 0158) Flagstaff, Arizona, United States
- The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0120) Peoria, Arizona, United States
- The Institute for Liver Health II dba Arizona Liver Health-Tucson ( Site 0111) Tucson, Arizona, United States